The UK government has released an updated register of brokers authorized to deal in human medicines, providing essential information including company names, registration details, and addresses. This move is part of the ongoing effort to enhance transparency and regulatory compliance within the pharmaceutical supply chain.
With the increasing complexity of global supply chains and the heightened scrutiny on pharmaceutical distribution practices, this register serves as a critical resource for B2B professionals in the pharma sector. Regulatory, QA/QC, CMC, and sourcing teams can leverage this information to ensure they are engaging with compliant and reputable brokers, thereby mitigating risks associated with the procurement and distribution of human medicines.
As the industry continues to adapt to evolving regulations and market dynamics, access to reliable data on authorized brokers will be indispensable. This initiative underscores the importance of maintaining rigorous standards in the pharmaceutical supply chain, ultimately safeguarding public health and ensuring the integrity of medicinal products.
Get started today with Solo access →
